Cargando…

Understanding vaccine hesitancy with PCV13 in children: Results of a survey in Shanghai, China

A questionnaire survey for parents of children under 5 years of age was conducted to analyze vaccine hesitancy with the 13-valent pneumococcal conjugate vaccine (PCV13) in Shanghai, China. A total of 892 valid questionnaires were collected. Descriptive statistical methods, Chi-square test and effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ni, Yi-hong, Xu, Zhen-hui, Wang, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138253/ https://www.ncbi.nlm.nih.gov/pubmed/37104479 http://dx.doi.org/10.1371/journal.pone.0284810

Ejemplares similares

The demographics of vaccine hesitancy in Shanghai, China
por: Ren, Jia, et al.
Publicado: (2018)

Vaccine hesitancy and receipt of mandatory and optional pediatric vaccines in Shanghai, China
por: Ji, Mengdi, et al.
Publicado: (2022)

2703. Pneumococcal Carriage of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Non-PCV13 Serotypes among Greek Children Vaccinated with PCV13 in a 3 + 1 Schedule During the First 6 years after the Fourth Dose of PCV13
por: Syrogiannopoulos, George A, et al.
Publicado: (2019)

Nasopharyngeal Pneumococcal Carriage among Healthy Children in Cyprus Post Widespread Simultaneous Implementation of PCV10 and PCV13 Vaccines
por: Hadjipanayis, Adamos, et al.
Publicado: (2016)

Factors Associated with PCV13 Vaccine Hesitancy in Parents under an Innovative Immunization Strategy: a Cross-Sectional Study — Weifang City, Shandong Province, China, 2021
por: Du, Yuanze, et al.
Publicado: (2023)

Understanding COVID-19 vaccine demand and hesitancy: A nationwide online survey in China
por: Lin, Yulan, et al.
Publicado: (2020)

Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants
por: Perdrizet, Johnna, et al.
Publicado: (2020)

The SARS-CoV-2 vaccination rate and hesitation in Shanghai older adults with dementia
por: Yang, Yang, et al.
Publicado: (2023)

Effectiveness of 13-pneumococcal conjugate vaccine (PCV13) against invasive pneumococcal disease in children in the Dominican Republic
por: Tomczyk, Sara, et al.
Publicado: (2018)

Antibiotic Prescription Rates in Children <24 Months Old Following PCV7/PCV13 Sequential Implementation
por: Dagan, Ron, et al.
Publicado: (2017)

Effectiveness of Pneumococcal Conjugate Vaccines (PCV7 and PCV13) against Invasive Pneumococcal Disease among Children under Two Years of Age in Germany
por: van der Linden, Mark, et al.
Publicado: (2016)

An assessment of PCV13 vaccine coverage using a repeated cross-sectional household survey in Malawi
por: Bondo, Austin, et al.
Publicado: (2018)

Understanding Drivers of Vaccine Hesitancy During the COVID-19 Pandemic Among Older Adults in Jiangsu Province, China: Cross-sectional Survey
por: Yang, Liuqing, et al.
Publicado: (2023)

Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to the 10-Valent Pneumococcal Conjugate Vaccine (PCV10) in Italy
por: Ansaldi, Filippo, et al.
Publicado: (2020)

Hospitalization costs for children with pneumonia in Shanghai, China from 2019 to 2020
por: Wang, Jing, et al.
Publicado: (2022)

Understanding Vaccine Hesitancy in Vietnamese Fish Farmers
por: Chambers, Julie A., et al.
Publicado: (2022)

Molecular Epidemic Characteristics and Genetic Evolution of Porcine Circovirus Type 2 (PCV2) in Swine Herds of Shanghai, China
por: Kang, Le, et al.
Publicado: (2022)

Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden
por: Galanis, Ilias, et al.
Publicado: (2016)

Understanding vaccine hesitancy in COVID-19
por: Trogen, Brit, et al.
Publicado: (2021)

Parental Seasonal Influenza Vaccine Hesitancy and Associated Factors in Shanghai, China, during the COVID-19 Pandemic: A Cross-Sectional Study
por: Fan, Jingyi, et al.
Publicado: (2022)

Introduction of multi-dose PCV 13 vaccine in Benin: from the decision to vaccinators experience
por: Abdoulaye Alfa, Daleb, et al.
Publicado: (2020)

The Genomics of Streptococcus pneumoniae Carriage Isolates from UK Children and Their Household Contacts, Pre-PCV7 to Post-PCV13
por: Sheppard, Carmen L., et al.
Publicado: (2019)

2903. Post PCV13 Dynamics of NonVaccine Serotype (NVT): Disproportionate Increase of the Additional PCV20 Candidate Serotypes in Respiratory and Invasive Disease in Young Children
por: Ben-Shimol, Shalom, et al.
Publicado: (2019)

1479. Incidence of Acute Otitis Media in Children in the United States before and after the introduction of Pneumococcal Conjugate Vaccines (PCV7 and PCV13) during 1998-2018
por: Hu, Tianyan, et al.
Publicado: (2020)

1735. Impact of Children Universal Pneumococcal Vaccination (PCV7v/PCV13v) on Pneumococcal Invasive Disease Hospitalizations in a Private General Hospital, Uruguay
por: Sanchez-Varela, Mercecedes, et al.
Publicado: (2023)

Response to PCV13 vaccination in patients with multiple myeloma versus healthy controls
por: Mustafa, S. Shahzad, et al.
Publicado: (2018)

Potentiating pneumococcal glycoconjugate vaccine PCV13 with saponin adjuvant VSA-1
por: Kim, Hyunjung, et al.
Publicado: (2022)

Towards understanding vaccine hesitancy and vaccination refusal in Austria
por: Bauer, Anja, et al.
Publicado: (2020)

1480. Incidence of Non-Invasive Pneumococcal Pneumonia in Children in the United States before and after Introduction Pneumococcal Conjugate Vaccines (PCV7 and PCV13) during 1998-2018
por: Hu, Tianyan, et al.
Publicado: (2020)

How nasopharyngeal pneumococcal carriage evolved during and after a PCV13-to-PCV10 vaccination programme switch in Belgium, 2016 to 2018
por: Wouters, Ine, et al.
Publicado: (2020)

Targeting COVID-19 vaccine hesitancy among nurses in Shanghai: A latent profile analysis
por: Zhang, Enming, et al.
Publicado: (2022)

A review of economic evaluations of 13-valent pneumococcal conjugate vaccine (PCV13) in adults and the elderly
por: Dirmesropian, S, et al.
Publicado: (2015)

1441. Doses of 13-Valent Conjugated Pneumococcal Vaccine (PCV13) for Patients With Multiple Myeloma (MM)
por: Sun, Hsin-Yun, et al.
Publicado: (2018)

Vaccine hesitancy: understanding better to address better
por: Kumar, Dewesh, et al.
Publicado: (2016)

The Prevalence and Genetic Diversity of PCV3 and PCV2 in Colombia and PCV4 Survey during 2015–2016 and 2018–2019
por: Vargas-Bermudez, Diana S., et al.
Publicado: (2022)

A bivalent porcine circovirus type 2 (PCV2), PCV2a-PCV2b, vaccine offers biologically superior protection compared to monovalent PCV2 vaccines
por: Bandrick, Meggan, et al.
Publicado: (2022)

Population genomics of pneumococcal carriage in Massachusetts children following introduction of PCV-13
por: Mitchell, Patrick K., et al.
Publicado: (2019)

Pneumococcal serotypes in children, clinical presentation and antimicrobial susceptibility in the PCV13 era
por: Izquierdo, C., et al.
Publicado: (2020)

Effect on nasopharyngeal pneumococcal carriage of replacing PCV7 with PCV13 in the Expanded Programme of Immunization in The Gambia
por: Roca, Anna, et al.
Publicado: (2015)

Comparison of early effects of pneumococcal conjugate vaccines: PCV7, PCV10 and PCV13 on Streptococcus pneumoniae nasopharyngeal carriage in a population based study; The Palestinian-Israeli Collaborative Research (PICR)
por: Abu Seir, Rania, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rfkihu6t6hdgh123gcpc543t53